For instance, patients with systemic sclerosis and/or systemic lupus erythematosus (SLE) were demonstrated to have deficient B cell activation response after Toll-like receptor (TLR)-9 stimulation (13, 14). The gene discussed is TLR9; the disease is systemic lupus erythematosus.